TherapeuticsMD (TXMD) Share-based Compensation (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Share-based Compensation came in at $2000.0 in Q1 2026, down 91.3% YoY from $23000.0 in Q1 2025, and down 96.08% on a QoQ basis from $51000.0 in Q4 2025.
TherapeuticsMD (TXMD) Share-based Compensation (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Share-based Compensation data on file, last reported at $2000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 91.3% year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54000.0 (down 69.32% YoY) and the FY2025 annual result came in at $75000.0, down 71.59% from the prior year.
- Share-based Compensation fell to $2000.0 in Q1 2026, from $51000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $12.2 million in Q2 2022 to a low of $1000.0 in Q2 2025.
- A 5-year average of $1.4 million and a median of $113500.0 in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 5250.88% — and 2025, when it plunged 98.96%.
- Tracing TXMD's Share-based Compensation over 5 years: stood at $1.1 million in 2022, then tumbled by 89.45% to $116000.0 in 2023, then sank by 79.31% to $24000.0 in 2024, then soared by 112.5% to $51000.0 in 2025, then tumbled by 96.08% to $2000.0 in 2026.
- The last three Share-based Compensation figures came in at $2000.0 (Q1 2026), $51000.0 (Q4 2025), and $1000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Dec 31, 2023 | 116,000.00 |